Lupin gets USFDA nod to market generic drugs in USAuthorPosted byPublishedJune 3, 202412:18 pmX (Twitter)FacebookLinkedInShare this postShare this postClose sharing boxLupin gets USFDA nod to market generic drugs in USX (Twitter)FacebookLinkedInPosted by on June 3, 2024. The product is the generic equivalent of Merck Sharp & Dohme LLC’s Prevymis tablets (240 mg and 480 mg) Post Views: 20
Nifty 50, Sensex today: What to expect from Indian stock market in trade on May 27 | Stock Market News – Mint